INOVIO Reports Inducement Grant Under Inducement Plan MarketScreener

PLYMOUTH MEETING, Pa., April 3, 2023 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that it has made an equity grant to its newly hired Senior Vice President, Regulatory Affairs under its 2022 Inducement Plan (the “Inducement Plan”). The Compensation Committee of INOVIO’s Board of Directors has approved the award of restricted stock units (“RSUs”) covering an aggregate of 45,000 shares of common stock and options to purchase an aggregate of 70,000 shares of common stock, with a…